搜尋
Akoustis Technologies Ord Shs
AKTS添加自選
24.010USD
-0.800-3.22%
收盤 07-23 16:00（美東）報價延遲15分鐘
1.22B總市值
虧損本益比TTM
關於 Akoustis Technologies Ord Shs 公司
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Akoustis Technologies Ord Shs簡介
公司代碼AKTS
公司名稱Aktis Oncology Inc
上市日期Jan 09, 2026
CEORoden (Matthew)
員工數量117
證券類型Ordinary Share
年結日Jan 09
公司地址17 Drydock Avenue
城市BOSTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編02210
電話13026587581
網址https://www.aktisoncology.com/
公司代碼AKTS
上市日期Jan 09, 2026
CEORoden (Matthew)
Akoustis Technologies Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Arthur E. Geiss, Ph.D.
Mr. Arthur E. Geiss, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Jerry D. Neal, Ph.D.
Dr. Jerry D. Neal, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ms. Jill K. Frizzley
Ms. Jill K. Frizzley
Independent Director
Independent Director
--
--
Mr. Matthew R. Kahn, CPA
Mr. Matthew R. Kahn, CPA
Independent Director
Independent Director
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board of Director
Chairman of the Board of Director
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kyle D. Kuvalanka
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Matthew (Matt) Roden, Ph.D.
Mr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Arthur E. Geiss, Ph.D.
Mr. Arthur E. Geiss, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Jerry D. Neal, Ph.D.
Dr. Jerry D. Neal, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Mr. Paul L. Feldman, Ph.D.
Mr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ms. Jill K. Frizzley
Ms. Jill K. Frizzley
Independent Director
Independent Director
--
--
常見問題
Akoustis Technologies Ord Shs的前五大股東是誰？
Akoustis Technologies Ord Shs的前五大股東如下：Mr. Matthew (Matt) Roden, Ph.D.
有多少機構持有Akoustis Technologies Ord Shs(AKTS)的股份？
截至2026Q1，共有195家機構持有Akoustis Technologies Ord Shs的股份，合計持有的股份價值約為27.52M，占公司總股份的51.47% 。與2025Q4相比，機構持股有所增加，增幅為1127277.00。